Showing results (11-20 of 231) with videos related to
Sort By:
Pageof 24
Contact Dermatitis|September 13, 2002
Epidemiology of contact allergy: an estimation of morbidity employing the clinical epidemiology and drug-utilization research (CE-DUR) approachA Schnuch, W Uter, J Geier, et al.Allergy|November 1, 2006
A high-positive patch test load correlates with further positive patch test reactions irrespective of their locationJ Brasch, J Geier, A Schnuch, et al.Contact Dermatitis|May 10, 2002
The preservative iodopropynyl butylcarbamate: frequency of allergic reactions and diagnostic considerationsA Schnuch, J Geier, J Brasch, et al.American Journal of Contact Dermatitis : Official Journal of the American Contact Dermatitis Society|December 26, 2001
Associated positive patch test reactions to standard contact allergensJ Brasch, W Uter, J Geier, et al.Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|August 28, 2003
[Epidemiologic surveillance of contact allergens. The "monitoring series" of IVDK (Information Network ofDermatologic Clinics for Detection and Scientific Evaluation of Contact Allergy]W Aberer, P Komericki, W Uter, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|February 21, 2007
Patch test results with patients' own perfumes, deodorants and shaving lotions: results of the IVDK 1998-2002W Uter, J Geier, A Schnuch, et al.The British Journal of Dermatology|May 15, 1998
Patch testing with preservatives, antimicrobials and industrial biocides. Results from a multicentre studyA Schnuch, J Geier, W Uter, et al.Contact Dermatitis|February 24, 2001
Contact allergy to Disperse Blue 106 and Disperse Blue 124 in German and Austrian patients, 1995 to 1999W Uter, J Geier, H Lessmann, et al.European Journal of Dermatology : EJD|July 3, 1998
Epidemiology of contact dermatitis. The information network of departments of dermatology (IVDK) in GermanyW Uter, A Schnuch, J Geier, et al.The British Journal of Dermatology|September 21, 2004
Iodopropynylbutyl carbamate 0.2% is suggested for patch testing of patients with eczema possibly related to preservativesJ Brasch, A Schnuch, J Geier, et al.Pageof 24